Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Chemistry Outsourcing

Jim Zhang's Biography

Jim Zhang, President, JZMed

Jim J. Zhang, Ph.D., is president and managing director of JZMed, Inc., a leading market research company that specializes in the research of global pharmaceutical outsourcing industry with emphasis on the emerging markets, especially China and India.

Before founding the company, Jim worked for nine years with Albany Molecular Research, Inc. (AMRI), a US-based and currently one of the world largest CROs. During his tenure at AMRI Jim was responsible for managing and overseeing multiple drug R&D projects that involved the international cooperation of AMRI’s multiple sites (USA, Singapore and Hungary). He played key roles in helping numerous pharma and biotech companies discover and develop a series of drug candidates that later entered preclinical and clinical development including advanced clinical trials. He was also the key contributor to the development of chemical production process for several developmental drugs.

Jim’s technical expertise spans from chemical process research and development to drug discovery and development for viral infection, cancer, chronic obstructive pulmonary disease (COPD) and cystic fibrosis. Currently he holds 18 patents. He is also the principal author of 12 peer-reviewed research articles.

Jim received his master’s degree in Chemical Engineering from East China University of Science & Technology (Shanghai), and his Ph.D. degree in Synthetic Organic Chemistry from the University of Iowa. He also received additional trainings in Medicinal Chemistry through working at Research Triangle Institute (Research Triangle Park, North Carolina).

Jim Zhang Image

Emerging Outsourcing Destinations

Wednesday, 14 March 2012 at 15:45

Add to Calendar ▼2012-03-14 15:45:002012-03-14 16:45:00Europe/LondonEmerging Outsourcing Destinations

The presentation will discuss both in depth and in detail a series of new outsourcing strategies currently implemented by global drug companies in the emerging markets and the strengths and weakness of the service providers in these countries.

Add to Calendar ▼2012-03-13 00:00:002012-03-14 00:00:00Europe/LondonChemistry